Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 2005, p. 406-407, Vol. 49, No. 1
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.1.406-407.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Institute of Medical Microbiology and Hygiene,1 Institute of Anatomy University of Luebeck, Luebeck, Germany2
Received 2 August 2004/ Returned for modification 12 August 2004/ Accepted 7 September 2004
Quinolone resistance of Chlamydia pneumoniae has not been described previously. Serial subcultures of C. pneumoniae under increasing moxifloxacin concentrations (0.0125 to 6.4 mg/liter) resulted in a 256-fold MIC increase compared to moxifloxacin-naive strains. GyrA gene sequencing revealed a novel point mutation with a Ser
Asn substitution. Subcultures under rifalazil and macrolides did not alter the respective MICs.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |